Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001072613-12-000715
Filing Date
2012-12-19
Accepted
2012-12-19 17:33:19
Documents
2
Period of Report
2012-12-18

Document Format Files

Seq Description Document Type Size
1 CHP III LP FORM 4 chpiii4-0121812_17438.html 4  
1 CHP III LP FORM 4 chpiii4-0121812_17438.xml 4 4612
2 chp-poa_17438.txt EX-24 3570
  Complete submission text file 0001072613-12-000715.txt   9799
Mailing Address C/O CARDINAL HEALTH PARTNERS 230 NASSAU STREET PRINCETON NJ 08542
Business Address C/O CARDINAL HEALTH PARTNERS 230 NASSAU STREET PRINCETON NJ 08542 6099246452
CHP III LP (Reporting) CIK: 0001384619 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35403 | Film No.: 121275339

Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations